Hernández, Juan Jesús Cruz http://orcid.org/0000-0003-1980-2751
Arrula, Virginia Arrazubi
Álvarez, Yolanda Escobar
Castaño, Almudena García
de Castro, Juan José Grau
Docampo, Lara Iglesias
Sorrosal, Julio Lambea
Segura, Pedro Pérez
Domínguez, Antonio Rueda
Campos-Lucas, Francisco J.
Rodríguez, Irene Santamaría
Bessa, Maria
Gratal, Paula
Caballero-Martínez, Fernando
Martín, Diana Monge
Antón-Rodríguez, Cristina
López, Rafael
Funding for this research was provided by:
Bristol-Myers Squibb
Universidad de Salamanca
Article History
Received: 18 May 2023
Accepted: 25 July 2023
First Online: 17 October 2023
Declarations
:
: Virginia Arrazubi Arrula declares receiving honoraria for participation in advisory boards from MSD and BMS and Merck; and travel, accommodations and expenses from MSD, Merck and Lilly. Yolanda Escobar Álvarez reports receiving honoraria for participation in advisory boards from MSD and BMS and Merck; and travel, accommodations and expenses from MSD, Merck and BMS. Almudena García Castaño reports receiving honoraria for participation in advisory boards from MSD, BMS and Novartis; and travel, accommodations and expenses from MSD, BMS, Merk and Pierre Fabre. Lara Iglesias Docampo has received advisory honoraria from Merck, MSD, BMS, Lilly, and Roche; speaker fees from Merck, MSD, BMS, Roche, Bayer, and Sanofi; and travel, accommodations and expenses from Merck and MSD. Julio Lambea Sorrosal has received honoraria for participation in advisory boards from MSD, BMS and Merck; and travel, accommodations and expenses from MSD, BMS, and Merck. Pedro Pérez Segura has received honoraria for participation in advisory boards from MSD, BMS and Merck; and travel, accommodations and expenses from MSD, BMS, and Merck. Antonio Rueda Domínguez has received honoraria for participation in advisory boards from MSD, BMS and Merck; and travel, accommodations and expenses from MSD, BMS, and Merck. Rafael López has received honoraria for participation in advisory boards from Roche, AstraZeneca, Merck, MSD, Bayer, BMS, Novartis, Janssen, Lilly, Pfizer and Leo; travel, accommodations and expenses from Pharmamar, Roche, BMS and Pierre Fabre; research funding from Roche and Merck; and is the co-founder and a shareholder in Nasasbiotech, Diversa Technologies. Juan Jesús Cruz Hernández, Juan José Grau de Castro, Francisco J. Campos-Lucas, Irene Santamaría Rodríguez, Maria Bessa, Paula Gratal, Fernando Caballero-Martínez, Diana Monge Martín, and Cristina Antón-Rodríguez have no competing interests to declare that are relevant to the content of this article.
: This study did not involve humans and did not require approval from an Ethical Committee.
: This study did not involve humans and informed consent was not necessary.